Sartorius Aktiengesellschaft

XTRA:SRT 株式レポート

時価総額:€13.1b

Sartorius 過去の業績

過去 基準チェック /26

Sartoriusは、平均年間6.6%の収益成長を遂げていますが、 Life Sciences業界の収益は、年間 成長しています。収益は、平均年間13.9% 13.2%収益成長率で 成長しています。 Sartoriusの自己資本利益率は3.4%であり、純利益率は2.3%です。

主要情報

6.6%

収益成長率

3.1%

EPS成長率

Life Sciences 業界の成長26.8%
収益成長率13.2%
株主資本利益率3.4%
ネット・マージン2.3%
次回の業績アップデート28 Jan 2025

最近の業績更新

Recent updates

Sartorius (ETR:SRT) Has A Pretty Healthy Balance Sheet

Jul 12
Sartorius (ETR:SRT) Has A Pretty Healthy Balance Sheet

Why The 23% Return On Capital At Sartorius (ETR:SRT) Should Have Your Attention

Jun 24
Why The 23% Return On Capital At Sartorius (ETR:SRT) Should Have Your Attention

If You Like EPS Growth Then Check Out Sartorius (ETR:SRT) Before It's Too Late

Jun 06
If You Like EPS Growth Then Check Out Sartorius (ETR:SRT) Before It's Too Late

Here's Why Sartorius (ETR:SRT) Can Manage Its Debt Responsibly

Mar 28
Here's Why Sartorius (ETR:SRT) Can Manage Its Debt Responsibly

We Think Sartorius' (ETR:SRT) Robust Earnings Are Conservative

Feb 23
We Think Sartorius' (ETR:SRT) Robust Earnings Are Conservative

Investors Interested In Sartorius Aktiengesellschaft's (ETR:SRT) Earnings

Feb 21
Investors Interested In Sartorius Aktiengesellschaft's (ETR:SRT) Earnings

If You Like EPS Growth Then Check Out Sartorius (ETR:SRT) Before It's Too Late

Jan 20
If You Like EPS Growth Then Check Out Sartorius (ETR:SRT) Before It's Too Late

Sartorius (ETR:SRT) Is Achieving High Returns On Its Capital

Nov 25
Sartorius (ETR:SRT) Is Achieving High Returns On Its Capital

Does Sartorius (ETR:SRT) Have A Healthy Balance Sheet?

Oct 21
Does Sartorius (ETR:SRT) Have A Healthy Balance Sheet?

Do Sartorius's (ETR:SRT) Earnings Warrant Your Attention?

Aug 29
Do Sartorius's (ETR:SRT) Earnings Warrant Your Attention?

Sartorius (ETR:SRT) Hasn't Managed To Accelerate Its Returns

Aug 12
Sartorius (ETR:SRT) Hasn't Managed To Accelerate Its Returns

These 4 Measures Indicate That Sartorius (ETR:SRT) Is Using Debt Reasonably Well

Jul 06
These 4 Measures Indicate That Sartorius (ETR:SRT) Is Using Debt Reasonably Well

Does Sartorius (ETR:SRT) Deserve A Spot On Your Watchlist?

May 12
Does Sartorius (ETR:SRT) Deserve A Spot On Your Watchlist?

Sartorius Aktiengesellschaft's (ETR:SRT) CEO Will Probably Have Their Compensation Approved By Shareholders

Mar 20
Sartorius Aktiengesellschaft's (ETR:SRT) CEO Will Probably Have Their Compensation Approved By Shareholders

Is Sartorius Aktiengesellschaft's (ETR:SRT) Shareholder Ownership Skewed Towards Insiders?

Feb 22
Is Sartorius Aktiengesellschaft's (ETR:SRT) Shareholder Ownership Skewed Towards Insiders?

Our Take On The Returns On Capital At Sartorius (ETR:SRT)

Feb 04
Our Take On The Returns On Capital At Sartorius (ETR:SRT)

Here's Why We Think Sartorius (ETR:SRT) Is Well Worth Watching

Jan 13
Here's Why We Think Sartorius (ETR:SRT) Is Well Worth Watching

Can Sartorius Aktiengesellschaft (ETR:SRT) Maintain Its Strong Returns?

Dec 24
Can Sartorius Aktiengesellschaft (ETR:SRT) Maintain Its Strong Returns?

What Type Of Shareholders Make Up Sartorius Aktiengesellschaft's (ETR:SRT) Share Registry?

Nov 18
What Type Of Shareholders Make Up Sartorius Aktiengesellschaft's (ETR:SRT) Share Registry?

収支内訳

Sartorius の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

XTRA:SRT 収益、費用、利益 ( )EUR Millions
日付収益収益G+A経費研究開発費
30 Sep 243,32477883184
30 Jun 243,34178883176
31 Mar 243,312149862170
31 Dec 233,396205851171
30 Sep 233,608358847180
30 Jun 233,850495845179
31 Mar 234,053566844181
31 Dec 224,175678830178
30 Sep 224,035534826162
30 Jun 223,880489797157
31 Mar 223,683434779150
31 Dec 213,449319746140
30 Sep 213,183372689131
30 Jun 212,908332644125
31 Mar 212,617254599115
31 Dec 202,336210565108
30 Sep 202,151181535105
30 Jun 201,989154514100
31 Mar 201,90116549499
31 Dec 191,82715747896
30 Sep 191,76817146485
30 Jun 191,70216645282
31 Mar 191,63715344179
31 Dec 181,56614142578
30 Sep 181,51813841676
30 Jun 181,46012640175
31 Mar 181,42611539074
31 Dec 171,40511538169
30 Sep 171,3769137169
30 Jun 171,3779636265
31 Mar 171,34110534562
31 Dec 161,30010333359
30 Sep 161,2509932259
30 Jun 161,20510131157
31 Mar 161,1599630253
31 Dec 151,1158529353
30 Sep 151,0767628444
30 Jun 151,0036127544
31 Mar 159464726751
31 Dec 148914426044
30 Sep 147804322846
30 Jun 147734222947
31 Mar 147804623248
31 Dec 137924823348

質の高い収益: SRTは 高品質の収益 を持っています。

利益率の向上: SRTの現在の純利益率 (2.3%)は、昨年(9.9%)よりも低くなっています。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: SRTの収益は過去 5 年間で年間6.6%増加しました。

成長の加速: SRTは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。

収益対業界: SRTは過去 1 年間で収益成長率がマイナス ( -78.5% ) となったため、 Life Sciences業界平均 ( 5.4% ) と比較することが困難です。


株主資本利益率

高いROE: SRTの 自己資本利益率 ( 3.4% ) は 低い とみなされます。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘